Abiopharma

News list

Director CONESA ANDRES 🟢 acquired 128 shares (1 derivative) of SEMPRA (SRE) Transaction Date: Apr 01, 2026 | Filing ID: 000004

Full text

News bot April 2, 2026, 11:24 p.m.
🔍 CONESA ANDRES (Director)

Company: SEMPRA (SRE)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 128
Detailed Transactions and Holdings:
- Acquired 128 shares of Phantom Shares (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,516.80 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F4
Footnotes:
- F1: Phantom shares of Sempra Common Stock acquired as director compensation.
- F2: Conversion of Derivative Security is 1 for 1.
- F3: Date exercisable is immediate for shares that have vested.
- F4: Expiration date is Not Applicable.